Health Law

Read Mergers & Acquisitions Law updates, articles, and legal commentary from leading lawyers and law firms:

News & Analysis as of May 22, 2013

China Life Sciences Health Industry Client Briefing – April 2013 (May 15, 2013)

by Vicki Lung, Gordon B. Schatz, Katherine Yang, Amy Yin | Reed Smith on 5/15/2013

Pharmaceuticals, Medical Devices, Health Care & Life Sciences - ..Drugs - Approval of Innovative Drugs and Key Sector Generic Drugs to be Expedited (Shanghai Securities Journal 2013-04-23): Given the...more

How to Minimize FCPA Risk in Health Care Acquisitions

by Mintz Levin - Health Law on 5/10/2013

When acquiring a health care company doing business abroad, there is no such thing as being too thorough with anti-corruption due diligence. The Department of Justice and the Securities and Exchange Commission have the...more

China Life Sciences Health Industry Client Briefing – January 2013 (February 21, 2013)

by Vicki Lung, Mao Rong, Gordon B. Schatz, John Tan, May Ling Wong, Jay J. Yan, Katherine Yang, Amy Yin | Reed Smith on 2/22/2013

In This Issue: Li Keqiang Comments from the 12th Plenary Meeting of the Medical Reform Leading Group (USCBC 2012-01-06) – January 6, 2013; MOH Announces Roadmap for Medical Reform (USCBC 2012-01-10) – January 10, 2013;...more

Pharmaceutical Anti-Corruption Compliance Conference In Philadelphia December 11-12

by Thomas Fox on 12/4/2012

The pharmaceutical; medical device and medical supply industry have all been hit hard by Foreign Corrupt Practices Act (FCPA) enforcement actions. Just this summer, enforcement actions were announced against Pfizer which...more

It's Your Business Newsletter -- December 2012

by Julia P. Coelho, Timothy R. Deckert, Louis A. Dejoie, Megan F. Luck | McNees Wallace & Nurick LLC on 11/30/2012

In This Issue: ..Export Controls: Increased Enforcement Demands an Effective Export Compliance Program - United States exporters are subject to an extremely complex and often overlapping system of export...more

Inside M&A - Fall 2012

by Paul J. Kim, Nicolas Lafont, Obiamaka P. Madubuko, Jeffrey Rothschild, Jake Townsend | McDermott Will & Emery on 11/15/2012

In This Issue: Bridging the Cross-Border M&A Gap “Korean Style”; Corporate Buyers Beware: FCPA Successor Liability – A Growing Threat; Investing In the Chinese Health Care Sector: A New Frontier to be Explored with Care;...more

"The Global Competition Landscape: A Conversation With Sharis Pozen"

by Skadden, Arps, Slate, Meagher & Flom LLP on 10/25/2012

Skadden recently welcomed Sharis A. Pozen, former Acting Assistant Attorney General of the Antitrust Division of the U.S. Department of Justice, as a new partner in the firm’s Washington, D.C. office. Sharis discusses her DOJ...more

China Life Sciences and Health Industry Client Briefing – September 2012 (October 4, 2012)

by Reed Smith on 10/5/2012

In This Issue: • Merck-Simcere Joint Venture Starts Business in Pudong (Shanghai Daily 2012-09-13) – September 14, 2012 • Pfizer Joint Venture Set to Hire 600 Staff (Bloomberg News 2012-09-14) – September 14,...more

Life Sciences Health Industry China Briefing - June 2012 (July 20, 2012)

by Reed Smith on 7/26/2012

In This Issue: - China's Compulsory License Rule Has Drug Companies On Edge (Law360 2012-06 12) — June 14, 2012 - Beijing to Carry out Pilot Project of Separation of Dispensing from Prescription: Medical...more

An In-depth Insight into China's New Regulatory on Private Investment in Medical Institution

by Qin Qu on 6/12/2012

While the regulatory environment for foreign investment on medical institution is gradually loosening, with promising market prospective in both medical treatment and elderly care industries, enthusiasm from private investors...more